首页> 美国卫生研究院文献>Heliyon >Recent evolution on synthesis strategies and anti-leishmanial activity of β-carboline derivatives – An update
【2h】

Recent evolution on synthesis strategies and anti-leishmanial activity of β-carboline derivatives – An update

机译:最近β-咔啉衍生物合成策略和抗利尿术症的演变 - 更新

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Leishmaniasis is the most widespread pathogenic disease in several countries. Currently, no effective vaccines are available, and the control of Leishmaniasis primarily relies on decade-old chemotherapy. The treatment for the Leishmaniasis is not up to the mark. Current therapy for Leishmaniasis is ancient and requires hospitalization for the administration. These medications are also highly toxic and resistant. β-carboline, a natural indole containing alkaloid, holds a vital position in the field of medicinal chemistry with a diversified pharmacological action. The current review focuses mainly on the anti-leishmanial effects of β-carboline analogs and their synthetic strategies, structural activity relationship studies (SAR). The past ten years alterations unveiled by β-carboline analogs present in phytoconstituents and various derivatives of synthesized analogs with the mechanism of action were briefly shortlisted and illustrated.
机译:Leishmaniaisis是几个国家最普遍的致病疾病。目前,没有有效的疫苗,并且对LeishManiaisis的控制主要依赖于十年历史的化疗。 Leishmaniaisis的治疗不达到标记。 Leishmaniaisis的目前疗法是古老的,需要为管理提供住院治疗。这些药物也具有高度毒性和抗性。 β-咔啉,含有生物碱的天然吲哚,具有多样化的药理学作用的药物化学领域的重要地位。目前的审查主要集中在β-咔啉类似物的抗利什曼效应及其合成策略,结构活动关系研究(SAR)。在植物活组分中存在的β-咔啉类似物的过去十年的改变以及具有作用机制的合成类似物的各种衍生物的衍生物均短暂入围和说明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号